24 Hrs
Source:
وكالة الأنباء القطرية
Medications for obesity may lower death risk in mental health patients
A recent study has shown that obesity medications from the GLP-1 receptor agonist class, such as semaglutide, reduce the likelihood of death and cardiovascular complications in individuals with serious mental health conditions like schizophrenia, severe depression, and bipolar disorder. The results indicated that using these medications decreases the risk of mortality by approximately 24% over four years, with a 48% reduction after one year. The study clarified that patients with mental health disorders typically live 10 to 25 years less than others, and treatment with obesity medications enhances the chances of improving average life expectancy and reducing the risks of heart disease and diabetes.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)